Ross Osborn
Stock Analyst at Cantor Fitzgerald
(1.86)
# 2,979
Out of 4,832 analysts
105
Total ratings
30.53%
Success rate
-8.73%
Average return
Main Sectors:
Stocks Rated by Ross Osborn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SIBN SI-BONE | Reiterates: Overweight | $25 | $18.83 | +32.77% | 9 | May 6, 2025 | |
| NNOX Nano-X Imaging | Maintains: Overweight | $12 → $9 | $5.62 | +60.14% | 11 | Apr 1, 2025 | |
| SMTI Sanara MedTech | Reiterates: Overweight | $46 | $33.70 | +36.50% | 6 | Mar 26, 2025 | |
| LUCD Lucid Diagnostics | Reiterates: Overweight | $2 | $1.17 | +70.94% | 5 | Mar 26, 2025 | |
| ELUT Elutia | Reiterates: Overweight | $8 | $1.81 | +343.21% | 10 | Mar 7, 2025 | |
| AXGN Axogen | Reiterates: Overweight | $24 | $11.30 | +112.39% | 3 | Mar 5, 2025 | |
| NPCE NeuroPace | Maintains: Overweight | $19 → $20 | $14.89 | +34.32% | 5 | Mar 5, 2025 | |
| MDXG MiMedx Group | Reiterates: Overweight | $13 | $7.05 | +84.40% | 3 | Feb 27, 2025 | |
| CERS Cerus | Reiterates: Overweight | $4 | $1.29 | +210.08% | 4 | Feb 21, 2025 | |
| PRE Prenetics Global | Reiterates: Overweight | $9 | $5.40 | +66.67% | 7 | Jan 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $8 | $5.90 | +35.71% | 5 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $4.40 | +104.55% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $21 | $7.00 | +200.00% | 10 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $16 | $5.78 | +176.82% | 4 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $14 | $5.32 | +163.16% | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $96 | $83.24 | +15.33% | 1 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $3.5 | $1.13 | +211.11% | 5 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $2.5 | $0.48 | +425.71% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.25 | - | 7 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $3.10 | +61.29% | 2 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $8.61 | $0.72 | +1,101.51% | 2 | Aug 18, 2023 |
SI-BONE
May 6, 2025
Reiterates: Overweight
Price Target: $25
Current: $18.83
Upside: +32.77%
Nano-X Imaging
Apr 1, 2025
Maintains: Overweight
Price Target: $12 → $9
Current: $5.62
Upside: +60.14%
Sanara MedTech
Mar 26, 2025
Reiterates: Overweight
Price Target: $46
Current: $33.70
Upside: +36.50%
Lucid Diagnostics
Mar 26, 2025
Reiterates: Overweight
Price Target: $2
Current: $1.17
Upside: +70.94%
Elutia
Mar 7, 2025
Reiterates: Overweight
Price Target: $8
Current: $1.81
Upside: +343.21%
Axogen
Mar 5, 2025
Reiterates: Overweight
Price Target: $24
Current: $11.30
Upside: +112.39%
NeuroPace
Mar 5, 2025
Maintains: Overweight
Price Target: $19 → $20
Current: $14.89
Upside: +34.32%
MiMedx Group
Feb 27, 2025
Reiterates: Overweight
Price Target: $13
Current: $7.05
Upside: +84.40%
Cerus
Feb 21, 2025
Reiterates: Overweight
Price Target: $4
Current: $1.29
Upside: +210.08%
Prenetics Global
Jan 16, 2025
Reiterates: Overweight
Price Target: $9
Current: $5.40
Upside: +66.67%
Jan 13, 2025
Reiterates: Overweight
Price Target: $8
Current: $5.90
Upside: +35.71%
Jan 7, 2025
Initiates: Overweight
Price Target: $9
Current: $4.40
Upside: +104.55%
Dec 24, 2024
Reiterates: Overweight
Price Target: $21
Current: $7.00
Upside: +200.00%
Nov 5, 2024
Reiterates: Overweight
Price Target: $16
Current: $5.78
Upside: +176.82%
Oct 23, 2024
Reiterates: Overweight
Price Target: $14
Current: $5.32
Upside: +163.16%
Oct 15, 2024
Initiates: Neutral
Price Target: $96
Current: $83.24
Upside: +15.33%
Aug 8, 2024
Reiterates: Overweight
Price Target: $3.5
Current: $1.13
Upside: +211.11%
May 16, 2024
Reiterates: Overweight
Price Target: $2.5
Current: $0.48
Upside: +425.71%
Apr 12, 2024
Reiterates: Neutral
Price Target: n/a
Current: $2.25
Upside: -
Mar 1, 2024
Reiterates: Overweight
Price Target: $5
Current: $3.10
Upside: +61.29%
Aug 18, 2023
Reiterates: Neutral
Price Target: $8.61
Current: $0.72
Upside: +1,101.51%